1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Standards for the Conduct and Reporting of Health Technology Assessments : Ghana Reference Case of HTA and Economic Evaluations
- Contribution to journal › Article
- 2024
-
Mark
The transition of assessing health technologies to social interventions in Sweden
- Contribution to journal › Article
- 2012
-
Mark
Cost-utility analysis of adjuvant therapies for breast cancer in iran
- Contribution to journal › Article
- 2011
-
Mark
Cost-effectiveness of etanercept treatment in early active rheumatoid arthritis followed by dose adjustment.
- Contribution to journal › Article
- 2009
-
Mark
Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden
- Contribution to journal › Article
- 2007
-
Mark
Comparison of the cost-effectiveness of infliximab in the treatment of ankylosing spondylitis in the United Kingdom based on two different clinical trials
- Contribution to journal › Article
- 2004
-
Mark
Rehabilitation benefits highly motivated patients: a six-year prospective cost-effectiveness study
- Contribution to journal › Article
- 2003
-
Mark
Predicting survival in cost-effectiveness analyses based on clinical trials.
- Contribution to journal › Article
- 2002
-
Mark
Health promotion and disease prevention as a complement to community health indicators - Working group 1
- Contribution to journal › Article
-
Mark
Do changes in surgical procedures for breast cancer have consequences for hospital mean length of stay? A study of women operated on for breast cancer in Sweden, 1980-95.
- Contribution to journal › Article
